Jones, Dylan T <br/><br/>
Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand.  [electronic resource] 

 -  British journal of haematology  Jun 2003 
 - 713-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1048 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2141.2003.04340.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins<br/>Blotting, Western<br/>Caspase 3<br/>Caspases--metabolism<br/>Cytarabine--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Drug Interactions<br/>Humans<br/>Leukemia, Myeloid--drug therapy<br/>Membrane Glycoproteins--administration & dosage<br/>TNF-Related Apoptosis-Inducing Ligand<br/>Tumor Cells, Cultured<br/>Tumor Necrosis Factor-alpha--administration & dosage<br/>Vidarabine--administration & dosage